Histone deacetylase inhibitors - A new tool to treat cancer

Keyphrases

• Histone Deacetylase Inhibitor (HDACi) 100%
• Gene Regulation 40%
• Transcriptional Repression 40%
• Heterochromatin 40%
• Histone Deacetylases 40%
• Histone 40%
• Gene Expression 20%
• Polypeptide 20%
• Eukaryotes 20%
• In Cancer 20%
• Repressor 20%
• Transcriptional Regulation 20%
• Histone Modification 20%
• Acetylation 20%
• Pathological State 20%
• Solid Tumors 20%
• Cancer Therapy 20%
• Hematological Cancer 20%
• Chromatin 20%
• Transcription Regulation 20%
• Nuclear Envelope 20%
• Lamina-associated 20%
• Deacetylation 20%
• Cell Culture 20%
• Chromosomal Translocation 20%
• Chromatin Modification 20%
• Phase II Clinical Trial 20%
• Cancer-promoting 20%
• Hierarchical Process 20%
• Nuclear Envelope Proteins 20%
• Euchromatin 20%
• Phase Current 20%
• Neoplastic Transformation 20%
• Nuclear Periphery 20%
• Phase III Clinical Trial 20%
• Fusion Factor 20%
• Nucleosome Structure 20%
• Higher-order Chromatin Structure 20%
• Antiproliferation 20%

Biochemistry, Genetics and Molecular Biology

• Histone Deacetylase 100%
• Gene Expression 50%
• Transcription 50%
• Histone 50%
• Nuclear Membrane 33%
• Heterochromatin 33%
• Nucleosome 33%
• Nuclear Pore 33%
• Transcription Factors 16%
• Eukaryote 16%
• Cell Culture 16%
• Repressor 16%
• Acetylation 16%
• Clinical Trial 16%
• Deacetylation 16%
• Chromosomal Translocation 16%
• Chromatin Structure 16%
• Animal Model 16%
• Euchromatin 16%
• Histone Deacetylases Inhibitor 16%